New podcast – More on vaccine equity and S/F vaccines in the Americas

In focus / 27 May 2021

Photo: iStock

Our latest podcast episode features the audio version of our article on vaccine equity in the Americas, followed by an interview with the author, Danini Marin.


Be sure to listen in to the new Drug Safety Matters podcast episode for the audio version of our recent article, "Substandard and falsified COVID-19 vaccines in the Americas: Can vaccine equity help?"

After the long read, the author of the article, Danini Marin, joins host Federica Santoro to dig deeper into the state of the COVAX programme in the region, how organised crime is taking advantage of the pandemic, and why substandard and falsified vaccines pose such a serious risk to public vaccination programmes.

Danini Marin
"Substandard and falsified vaccines will most likely negatively impact people’s trust in vaccines."

Subscribe by visiting the Drug Safety Matters website or listen in right here:

This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the original article here.

After the read, we talk to Danini about the COVAX programme, organised crime, and trust in vaccinations.

You may also like


The One Health approach aims to uphold human, animal, and environmental health

The One Health approach emphasises how human, animal and environmental health are interlinked and must be prioritised to prevent future global health crises.

In focus / 20 February 2025

New film shines a light on Colombia’s pharmacovigilance journey

The latest "WHO PIDM in Focus" film highlights the collaboration between WHO, UMC, and Colombia in the development of medicines and vaccines safety in the country.

In focus / 27 February 2025

It takes a community to make medicines safer for all

The ‘PV in the Community’ special interest group explores how a community-focused approach can enhance medication safety and foster a more patient-centric pharmacovigilance system.

In focus / 10 March 2025